Trump Hails Bayer’s $2.2 Billion Ohio Pharma Campus as Tariff Win
Trump says Bayer will build a $2.2 billion pharmaceutical manufacturing campus near Columbus, Ohio, crediting his pharmaceutical tariffs for the investment.
WASHINGTON D.C. — Donald J. Trump said Bayer plans to build a $2.2 billion pharmaceutical manufacturing campus near Columbus, Ohio, crediting his pharmaceutical tariff policy for driving the investment.
Here is the full post on truthsocial: “HUGE NEWS FOR OHIO, where I am heading right now! Bayer just announced a brand new, 2.2 Billion Dollar Pharmaceutical Manufacturing Campus near Columbus. It will generate thousands of Jobs for Ohioans in Advanced Manufacturing, Scientific Research, Construction, and more. This massive Onshoring WIN is thanks to my strong Pharmaceutical Tariffs, which have led to over 600 BILLION DOLLARS in new Pharma Investments, and lower (MFN) Drug Prices. Companies everywhere are building in the U.S.A. BUILD IN AMERICA, HIRE AMERICAN WORKERS, AND PRICE DRUGS FOR AMERICAN PATIENTS FAIRLY — OR PAY. I LOVE OHIO! Trump” on October 3, 2026 at 6:20 PM ET.
This is Trump’s 3rd message released today, and the last post was 3 hours ago, and it is not part of a thread. On average, Trump produces 18 posts per day since his inauguration on January 20, 2025. The move fits a broader pattern in Trump’s recent messaging, with 5 of his 548 posts over the last 30 days classified as Tariffs posts.
President Donald J. Trump announced a new Bayer pharmaceutical manufacturing campus in Washington D.C.
Joyce N. Boghosian / The White House
© copyright Flickr with permission
Trump said the campus would generate thousands of jobs in advanced manufacturing, scientific research, and construction. He claimed his pharmaceutical tariffs had produced more than $600 billion in new pharmaceutical investments nationwide and had lowered most-favored-nation drug prices. Those figures come from Trump’s post and have not been independently verified by a cited source.
Trump closed the post with a direct warning to the pharmaceutical industry: “BUILD IN AMERICA, HIRE AMERICAN WORKERS, AND PRICE DRUGS FOR AMERICAN PATIENTS FAIRLY — OR PAY,” he said in the post, framing the Bayer announcement as a model for the sector.
Zenger analysis
Photo by Zenger analysis
President Trump is the author of Trump: The Art of the Deal, Trump: Think Like a Billionaire: Everything You Need to Know About Success, Real Estate, and Life, and Think Big: Make It Happen in Business and Life. Analyst and Trump supporter Rod Martin points to The Art of the Deal, Trump's 1987 book, as an explanation of his deal-making philosophy: making big announcements, pivoting often in public statements and, Martin says, ultimately getting what he wanted all along. Critics contend that Trump's books were published decades ago or were aimed at making money, not shedding light. "Generally," Martin said, "critics don't read The Art of the Deal. If they did, they would understand."